Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism

Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism

Introduction: Optimal neonatal nadroparin dosages to treat venous thromboembolism (VTE) are unknown. Objective: To evaluate therapeutic nadroparin dosages to reach therapeutic target ranges (TTR: 0.5–1.0 International Unit (IU)/mL) and the effectiveness and safety of nadroparin in neonatal VTE. Meth...

Full description

Bibliographic Details
Main Authors: Jeanine Sol, Marit Boerma, Irene Klaassen, Sinno Simons, Bregje Witjes, Enno Wildschut, Irwin Reiss, Cornelia Heleen van Ommen
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
neonate
thrombosis
nadroparin
therapeutic target range
effectiveness and safety
Online Access:https://www.mdpi.com/2077-0383/10/7/1483

Internet

https://www.mdpi.com/2077-0383/10/7/1483

Similar Items